ANNALEE NEDS: Open Payments
NPI 1871351817 · STANLEY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 2 | $31 |
| CeQur Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, CeQur Simplicity, MOUNJARO, BREZTRI, VRAYLAR, Dexcom G6 Transmitter, VOQUEZNA, Wegovy.
Industry payments across KS — which companies pay providers there.
